Making 2020 the Year of Professional Development

For makers, manufacturers, project managers, managers and data analysts, making time for training and upskilling employees and leaders could be a key competitive advantage in 2020

PORTLAND, Ore.–(BUSINESS WIRE)–#biojobs–More than 3,000 workers and managers can’t be wrong.

Releasing its industry-honed training and certificate calendar, Oregon Bioscience Association has scheduled more than 20 classes in the first half of 2020. The professional development-track sessions and a combination certificate program highlight process control and improvement, regulatory and compliance updates, Lean Six Sigma methods, ISO 13485:2016 standardization, high performance teamwork, communications, data analysis, FDA requirements, and quality management and improvement.

“We develop this unparalleled curricula with the advanced manufacturing, life science and biotechnology skilled workers in mind,” said Oregon Bio’s Executive Director Liisa Bozinovic. “A steering committee comprising inter-industry professionals and executives guide the development of our broad-based curriculum and cohorts to ensure our various industry sectors benefit from up-to-date skills education.”

Since its launch in 2007 when the training program was developed, more than 3,000 employees and managers have taken classes under Oregon Bio’s professional training and certificate programs. “Our robust catalogue of training opportunities is sought after, as we work to deliver on-time and on-demand educational programs,” says Julie Black, director of member services and business development for Oregon Bio.

Classes happen in and around Portland. Class and program formats are uniquely suited to both incumbent workers/managers as well as those looking to transition into advanced manufacturing.

Highlighted classes and programs happening in 2019 and 2020 include:

Classes and certificate programs are open to members and non-members.

About Oregon Bio

The Oregon Bioscience Association seeks to create opportunity through advocacy, cultivation, education and group purchasing discounts for its members and the sector. Oregon Bio promotes the growth and quality of the bioscience industry in the region and continually seeks ways to support sustainability, acceleration and growth in the life science, bioscience, biotechnology and device manufacturing industries. Oregon Bio, a nonprofit membership association, affiliates with the Biotechnology Innovation Organization (BIO), and the Advanced Medical Technology Association.

The region’s most current bioscience economic impact study showed in 2017 Oregon’s growing bio footprint reached $10.7 billion, creating 47,238 jobs for $1.5 billion in wages across 820 business establishments. Between 2002-2017, total bioscience employment in Oregon jumped 72 percent among the five industry subsectors. Health-related R&D at Oregon hospitals and universities generated $669 million in economic activity in 2017. In 2015, federal research funding to Oregon institutions totaled more than $363 million. Venture capital investments in Oregon’s bioscience-related companies have increased in recent years and between 2014 to 2017, totaled $76.5 million.

Also growing is Oregon’s share of NIH funding. A 2018 report released by BIO shows Oregon attracted 1,274 bioscience and related patents. The study also found Oregon is emerging in several bioscience areas, with job growth in four of the five major subsectors from 2007 to 2016.

For more information about Oregon Bioscience Association, please visit www.oregonbio.org. Connect with us on LinkedIn and Twitter.

Contacts

Dianne Danowski Smith, (503) 201-7019, @OregonBio, #oregonbio2019

 

Staff

Recent Posts

Grace Health Technology Launches New Laboratory Management Software

Live Sample Management Application Streamlines Laboratory Operations Software for Enhanced Laboratory Data Management Efficiency Secures…

5 hours ago

Avenues Recovery Center to Open at South Bend

Avenues Recovery is set to open a brand-new, 120-bed facility in Mishawaka, IndianaMISHAWAKA, IN /…

5 hours ago

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…

8 hours ago

Universal Recall Platform Alliance Launches to Keep Patients Safe

Industry initiative URPA broadens calls to improve speed, accuracy of recall communicationWEST HOLLYWOOD, CA /…

8 hours ago

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…

11 hours ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…

11 hours ago